Internalcarotid artery stenosis severity was significantly higher in symptomaticpatients than that in asymptomatic patients (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background: Carotid artery stenosis is the atherosclerotic narrowingof the proximal internal carotid artery and one of the primary causesof stroke.
📊
Key Findings & Data:Elevated expression of the pleiotropic proinflammatorycytokine interleukin-18 has been demonstrated in humanatherosclerotic plaques.Aims: To investigate whether the mRNA expression levels ofinterleukin-18 and interleukin-18-binding protein and interleukin-18−137 G/C (rs187238) variants are associated with carotid arterystenosis development.Study Design: Case-control study.Methods: The mRNA expression levels of interleukin-18 andinterleukin-18-binding protein and interleukin-18 rs187238 variantswere evaluated by quantitative real-time polymerase chain reactionand real-time polymerase chain reaction, respectively, in the peripheralblood mononuclear cells of 70 patients with carotid artery stenosis (36symptomatic, 34 asymptomatic) and 75 healthy controls.Results: Interleukin-18 mRNA expression was significantly increasedin carotid artery stenosis patients compared to that in healthy controls(p=0.01).
💡
Conclusion & Impact:Internalcarotid artery stenosis severity was significantly higher in symptomaticpatients than that in asymptomatic patients (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background: Carotid artery stenosis is the atherosclerotic narrowingof the proximal internal carotid artery and one of the primary causesof stroke. Elevated expression of the pleiotropic proinflammatorycytokine interleukin-18 has been demonstrated in humanatherosclerotic plaques.Aims: To investigate whether the mRNA expression levels ofinterleukin-18 and interleukin-18-binding protein and interleukin-18−137 G/C (rs187238) variants are associated with carotid arterystenosis development.Study Design: Case-control study.Methods: The mRNA expression levels of interleukin-18 andinterleukin-18-binding protein and interleukin-18 rs187238 variantswere evaluated by quantitative real-time polymerase chain reactionand real-time polymerase chain reaction, respectively, in the peripheralblood mononuclear cells of 70 patients with carotid artery stenosis (36symptomatic, 34 asymptomatic) and 75 healthy controls.Results: Interleukin-18 mRNA expression was significantly increasedin carotid artery stenosis patients compared to that in healthy controls(p=0.01). However, no significant difference was observed betweeninterleukin-18-binding protein mRNA expression levels in patientswith carotid artery stenosis and those in controls (p=0.101). Internalcarotid artery stenosis severity was significantly higher in symptomaticpatients than that in asymptomatic patients (p
🔖
Cite This Article
BAYOĞLU, B., DİRİCAN, A., DEŞER, S. B., ARAPİ, B., CENGİZ, M., ARSLAN, C., JUNUSBEKOV, Y. (2022). Increased Expression of Interleukin-18 mRNA is Associated with Carotid Artery Stenosis. Balkan Medical Journal, Cilt: 35 - Sayı: 3, 250–255. https://ajindex.com/articles/461048
Jefferis BJ, Papacosta O, Owen CG, Wannamethee SG, Humphries SE, Woodward M, et al. Interleukin 18 and coronary heart disease: Prospective study and systematic review. Atherosclerosis 2011;217:227-33.
Deser SB, Bayoglu B, Besirli K, Cengiz M, Arapi B, Junusbekov Y, et al. Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study. Heart Vessels 2016;31:976- 84. Wang J, Sun C, Gerdes N, Liu C, Liao M, Liu J, et al. Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter. Nat Med 2015;21:820-6.
Chang CH, Fan PC, Lin CY, Yang CH, Chen YT, Chang SW, et al. Elevation of Interleukin-18 Correlates with Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients. Medicine (Baltimore) 2015;94:e1836. Yan H, Ma Y, Li Y, Zheng X, Lv P, Zhang Y, et al. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation. Immunol Lett 2016;170:7-14.
Hernesniemi JA, Heikkilä A, Raitakari OT, Kähönen M, Juonala M, Hutri-Kähönen N, et al. Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study. Ann Med 2010;42:223-30.
Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schönbeck U. Expression of Interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245-57.
Zhang N, Yu JT, Yu NN, Lu RC, Ma T, Wang ND, et al. Interleukin-18 promoter polymorphisms and risk of ischemic stroke. Brain Res Bull 2010;81:590-4.
Liu W, Tang Q, Jiang H, Ding X, Liu Y, Zhu R, et al. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease. Angiology 2009;60:180-5.
Bayoglu B, Arslan C, Tel C, Ulutin T, Dirican A, Deser SB, et al. Genetic variants rs1994016 and rs3825807 in ADAMTS7 affect its mRNA expression in atherosclerotic occlusive peripheral arterial disease. J Clin Lab Anal 2018:32. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, Nagai Y, et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005;25:1458-62.
Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52. Ari